Oncology CPT® Codes for 2026 + Modifiers
Jan 27, 2026
Oncology billing spans complex consultations, chemotherapy administration, immunotherapy, radiation therapy, infusion services, drug wastage reporting, and high-cost treatment delivery. In 2026, oncology faces one of the most significant CPT® restructures in years—particularly in radiation oncology and supportive chemotherapy care. Using the correct Oncology CPT® codes and modifiers for 2026 is essential to prevent denials, protect revenue, and remain compliant in a highly scrutinized specialty.
Oncology denials aren’t random—they’re driven by documentation gaps, modifier errors, and 2026 radiation changes.
We consistently see rejected claims tied to incorrect radiation delivery coding, missing -JW/-JZ drug modifiers, infusion time documentation gaps, and improper E/M billing alongside chemotherapy. These are predictable denial triggers—and preventable.
Guarantee: We’ll identify the top denial causes in your oncology claims and provide a clear action plan to correct them.
Get My Oncology Denial Snapshot
Contact us to receive a Denial Snapshot showing why your oncology claims aren’t getting paid—and how to fix them.
Evaluation & Management (E/M) Codes for Oncology
Oncology care frequently involves complex decision-making, treatment planning, symptom management, and advance care planning discussions. When chemotherapy or infusion services occur on the same day as an office visit, E/M documentation must clearly stand alone to justify separate reimbursement.
| CPT® Code | Description |
|---|---|
| 99202–99205 | New patient office visits |
| 99212–99215 | Established patient office visits |
| 99221–99223 | Initial hospital care |
| 99231–99233 | Subsequent hospital care |
| 99238–99239 | Hospital discharge services |
| 99497 | Advance care planning (minimum 16 minutes; first 30 minutes billed) |
Documentation Tip: When billing E/M on the same day as chemotherapy administration, clearly document a significant, separately identifiable service beyond the routine pre-treatment assessment to support modifier -25.
E/M + chemo denials often happen because documentation doesn’t tell a separate story.
Payers heavily scrutinize 99213–99215 billed alongside infusion or chemo codes. Without clear assessment and decision-making documentation, claims deny as bundled.
Guarantee: We’ll pinpoint exactly why your E/M claims are denied and show you how to correct them.
Contact us for an oncology-specific E/M denial review.
Chemotherapy and Therapeutic Infusions
Chemotherapy and infusion coding follows strict hierarchy and time-based rules. Improper sequencing, incomplete time documentation, or misuse of additional-hour codes commonly results in denials.
| CPT® Code | Description |
|---|---|
| 96413 | Chemotherapy infusion, initial, up to 1 hour |
| 96415 | Chemotherapy infusion, each additional hour |
| 96409 | Chemotherapy IV push, single drug |
| 96411 | Chemotherapy IV push, additional drug |
| 96401 | Chemotherapy subcutaneous/intramuscular administration |
| 96365 | Therapeutic infusion, initial hour |
| 96366 | Therapeutic infusion, additional hour |
| 96367 | Therapeutic sequential infusion, additional drug |
| 96375 | Therapeutic IV push, sequential substance |
Hierarchy Reminder: Chemotherapy administration is primary. Therapeutic infusions are secondary. Hydration is last in hierarchy.
Infusion time errors are one of the most common oncology denial drivers.
If start/stop times aren’t documented precisely—or additional-hour thresholds aren’t met—claims deny or downcode.
Guarantee: We’ll identify infusion documentation gaps costing you reimbursement.
Contact us to analyze infusion-related denials.
New for 2026: Mechanical Scalp Cooling (Chemo Support Care)
Mechanical scalp cooling now has permanent Category I CPT® codes. These services reduce chemotherapy-induced alopecia and require proper documentation for measurement, calibration, and timed cooling periods.
| CPT® Code | Description |
|---|---|
| 97007 | Initial cap measurement/calibration and patient education |
| 97008 | Pre-cooling period (once per session) |
| +97009 | Post-infusion cooling (add-on; each 30 minutes) |
New codes mean new denial risks.
If your team hasn’t updated templates and charge capture for 97007–97009, rejected claims are likely.
Guarantee: We’ll confirm your workflows support proper reporting of scalp cooling services.
Radiation Oncology: The 2026 Technique-Agnostic “Complexity” Overhaul
Radiation treatment delivery is now billed by complexity level—not technique. This is a major structural shift.
Deleted for 2026: 77385, 77386, and 77014.
| CPT® Code | Complexity Level | Coverage |
|---|---|---|
| 77402 | Level 1 (Simple) | Includes imaging guidance when performed |
| 77407 | Level 2 (Intermediate) | Includes imaging guidance when performed |
| 77412 | Level 3 (Complex) | Includes imaging guidance when performed |
Bundling Alert: Technical image guidance is bundled into 77402–77412.
Billing deleted radiation codes will trigger automatic rejections.
If your system still uses 77385, 77386, or 77014, those claims will not pay in 2026.
Guarantee: We’ll audit your radiation coding transition for compliance risk.
New for 2026: Professional Image Guidance Code
77387 reports the professional component of IGRT. Append modifier -26 when reporting professional services only.
Oncology Modifiers for 2026
| Modifier | Description |
|---|---|
| -25 | Significant, separately identifiable E/M |
| -59 | Distinct procedural service |
| -XS | Separate structure |
| -76 | Repeat procedure |
| -91 | Repeat clinical diagnostic test |
| -JW | Drug wastage (separate line) |
| -JZ | Mandatory when zero waste occurs |
| -JG | 340B pricing |
| -26 | Professional component |
| -TC | Technical component |
Common ICD-10 Codes in Oncology
| ICD-10 Code | Description |
|---|---|
| C50.911 | Breast cancer, right side |
| C34.91 | Lung cancer |
| C61 | Prostate cancer |
| C20 | Rectal cancer |
| Z51.11 | Encounter for chemotherapy |
| Z51.12 | Encounter for immunotherapy |
| D05.1 | Lobular carcinoma in situ |
2026 Oncology Billing & Compliance Tips
- Use -JW or -JZ on applicable single-dose drug claims.
- Document infusion start and stop times precisely.
- Follow infusion hierarchy rules.
- Ensure radiation delivery coding reflects complexity level.
- Transition fully away from deleted codes.
Final Thoughts
Oncology billing in 2026 demands strict compliance with modifier reporting, infusion hierarchy, drug wastage documentation, and radiation delivery restructuring. Keeping your CPT® codes and documentation aligned with current standards protects revenue and reduces preventable denials.
If oncology denials are increasing, your workflow likely needs adjustment.
From infusion timing to radiation restructuring and mandatory drug modifiers, we know where oncology practices lose revenue—and how to stop it.
Guarantee: We’ll identify your top denial drivers and deliver a corrective action plan.
Trademark notice: CPT® is a registered trademark of the American Medical Association.
For informational purposes only.
Contact us
“My husband and I have a small practice but we were looking for a medical billing company to consult us. We originally started with a local company with some satisfaction. However, our biggest problem was that they wanted us to change our existing EMR to software that they worked with. Quest National Services worked with our existing software so that we didn’t have to make expensive changes to our infrastructure. That saved us a lot of time and headache. I would definitely say that was one of the main reasons for why we switched and why we continue to work with Quest. As a small practice, they helped us without draining our resources.”
Adriana C.
